These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 8617877

  • 61. IGF-I has no effect on postexercise suppression of the ubiquitin-proteasome system in rat skeletal muscle.
    Kee AJ, Taylor AJ, Carlsson AR, Sevette A, Smith RC, Thompson MW.
    J Appl Physiol (1985); 2002 Jun; 92(6):2277-84. PubMed ID: 12015337
    [Abstract] [Full Text] [Related]

  • 62. Skeletal muscle proteasome can degrade proteins in an ATP-dependent process that does not require ubiquitin.
    Driscoll J, Goldberg AL.
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):787-91. PubMed ID: 2536933
    [Abstract] [Full Text] [Related]

  • 63. [A new ATP-dependent protease complex in eukaryotes--degradation of ubiquitin-ligated proteins by association of a proteasome with its regulatory proteins].
    Tanaka K.
    Tanpakushitsu Kakusan Koso; 1991 Dec; 36(15):2494-505. PubMed ID: 1663639
    [No Abstract] [Full Text] [Related]

  • 64. Proteolysis, the ubiquitin-proteasome system, and renal diseases.
    Debigaré R, Price SR.
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F1-8. PubMed ID: 12788783
    [Abstract] [Full Text] [Related]

  • 65. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo.
    Fischer D, Gang G, Pritts T, Hasselgren PO.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):215-21. PubMed ID: 10733930
    [Abstract] [Full Text] [Related]

  • 66. An ATP-stabilized inhibitor of the proteasome is a component of the 1500-kDa ubiquitin conjugate-degrading complex.
    Driscoll J, Frydman J, Goldberg AL.
    Proc Natl Acad Sci U S A; 1992 Jun 01; 89(11):4986-90. PubMed ID: 1317579
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Increased expression of several components of the ATP dependant proteosome pathway in denervated rat muscle is reversed by beta 2-adrenergic agonists.
    Waddell ID, Ruddock P, Brocklehurst KJ, Wilbraham JM, Worral V, Holloway BR.
    Biochem Soc Trans; 1998 Nov 01; 26(4):S311. PubMed ID: 10047825
    [No Abstract] [Full Text] [Related]

  • 69. Role of ubiquitin-proteasome-dependent proteolytic process in degradation of muscle protein from diabetic rabbits.
    Galban VD, Evangelista EA, Migliorini RH, do Carmo Kettelhut I.
    Mol Cell Biochem; 2001 Sep 01; 225(1-):35-41. PubMed ID: 11716362
    [Abstract] [Full Text] [Related]

  • 70. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination.
    Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T, Tanaka K, Ichihara A.
    Nature; 1992 Dec 10; 360(6404):597-9. PubMed ID: 1334232
    [Abstract] [Full Text] [Related]

  • 71. Pathways of muscle protein breakdown in injury and sepsis.
    Hasselgren PO.
    Curr Opin Clin Nutr Metab Care; 1999 Mar 10; 2(2):155-60. PubMed ID: 10453347
    [Abstract] [Full Text] [Related]

  • 72. An enzyme related to the high molecular weight multicatalytic proteinase, macropain, participates in a ubiquitin-mediated, ATP-stimulated proteolytic pathway in soluble extracts of BHK 21/C13 fibroblasts.
    McGuire MJ, Reckelhoff JF, Croall DE, DeMartino GN.
    Biochim Biophys Acta; 1988 Nov 17; 967(2):195-203. PubMed ID: 2847802
    [Abstract] [Full Text] [Related]

  • 73. Regulation of proteolysis.
    Attaix D, Combaret L, Pouch MN, Taillandier D.
    Curr Opin Clin Nutr Metab Care; 2001 Jan 17; 4(1):45-9. PubMed ID: 11122559
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Proteasome expression in the skeletal muscles of patients with muscular dystrophy.
    Kumamoto T, Fujimoto S, Ito T, Horinouchi H, Ueyama H, Tsuda T.
    Acta Neuropathol; 2000 Dec 17; 100(6):595-602. PubMed ID: 11078210
    [Abstract] [Full Text] [Related]

  • 78. Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy.
    Jagoe RT, Redfern CP, Roberts RG, Gibson GJ, Goodship TH.
    Clin Sci (Lond); 2002 Mar 17; 102(3):353-61. PubMed ID: 11869177
    [Abstract] [Full Text] [Related]

  • 79. Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway.
    Gross-Mesilaty S, Hargrove JL, Ciechanover A.
    FEBS Lett; 1997 Mar 24; 405(2):175-80. PubMed ID: 9089286
    [Abstract] [Full Text] [Related]

  • 80. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer.
    Williams A, Sun X, Fischer JE, Hasselgren PO.
    Surgery; 1999 Oct 24; 126(4):744-9; discussion 749-50. PubMed ID: 10520924
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.